Arkolith/Insider Trading/SANA/Form 4

Wyrick Susan D.

See RemarksSana Biotechnology, Inc. (SANA) · full profile →Form 4 · filed Mar 10, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
2 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 10, 2025Tax withholding(F)836$2.56$2K157K
Mar 7, 2025Option exercise(M)3K—$0158K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 7, 2025Option exercise(M)3K—$010K
Mar 6, 2025Grant(A)42K—$042K
Mar 6, 2025Grant(A)188K—$0188K

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-25-002274) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML